CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.

As more and more people take Ozempic, Wegovy, Zepbound, and the like, rare side effects—like pancreatitis or even sudden blindness—will probably become increasingly apparent.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Middlesex County Popular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim Published: Jun. 19, 2025, 11:00 a.m.

3. Zepbound Zepbound is Mounjaro’s weight loss-approved counterpart. It’s another brand name for tirzepatide. Zepbound comes in the same dose as Mounjaro and works in the same way.

Pittman rejected a separate challenge in May brought by the same groups over the FDA's removal of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro from the shortage list.